Real-world data support trial data on the use of lutetium-177 PSMA-617 in patients with PSMA-positive, metastatic castration-resistant prostate cancer.

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

Investigators assessed whether MRI alone can identify all cases of Gleason grade group 2 or higher disease in patients on ...

Opioid prescriptions in the emergency department linked to small increases in hospital admission and subsequent opioid prescription use ...

Pain intensity linked to increased likelihood of using cigarettes, e-cigarettes, cannabis, lower likelihood of alcohol use ...

Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the US. The recipient of the genetically modified pig organ was a 66-year-old man with kidney ...

The Food and Drug Administration (FDA) has approved Emblaveo™ (aztreonam and avibactam), in combination with metronidazole, for patients 18 years and older who have limited or no alternative ...

The proportion of oncologists who were satisfied with their work-life integration decreased from 35% in 2013 to 24% in 2023. Burnout in US oncologists has increased over the past 10 years ...

Patients with CKD are at elevated risk for in-hospital mortality and other complications after undergoing elective cancer surgery. Patients with chronic kidney disease (CKD), and especially those ...